Sign inJoin waitlistJoin the waitlist

PC

Patrick Chun

Hematology & Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
UCLA David Geffen School of Medicine/UCLA Medical Center
2008–2012
Internal Medicine
Rhode Island Hospital/Brown University Health
2005–2008
Michigan State University College of Human Medicine
2000–2004

Research

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors
JCI Insight · 2018 · 125 citations
Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma
Cancer Research · 2006 · First of 6 authors · 67 citations
Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity
Oncogene · 2007 · 63 citations

Felix Feng
4 papers
TL
Theodore Lawrence
4 papers
Alex Adjei
1 paper
Antoni Ribas
1 paper
AS
Ashley Speilburg
1 paper
DM
Divya Maheshwari
1 paper
Gilbert Padula
1 paper
Hussein Tawbi
1 paper
Keith Flaherty
1 paper
RR
Ramesh Ramanathan
1 paper
Ryan Sullivan
1 paper
Scott Tomlins
1 paper